Innovative Virtual SOHO Breakthroughs Meeting to Address Blood Cancers on November 20, 2025

Virtual SOHO Breakthroughs in Blood Cancers Meeting Launching Nov 20, 2025

The Society of Hematologic Oncology (SOHO) is set to revolutionize the way healthcare professionals access groundbreaking information in hematological oncology by hosting its inaugural virtual SOHO Breakthroughs in Blood Cancers (SBBC) meeting on November 20, 2025. Chaired by the esteemed Dr. Hagop Kantarjian from the University of Texas MD Anderson Cancer Center, this event aims to provide crucial insights and clinical guidance straight to the practitioners who need it most.

Scheduled to run from 8 AM to 5 PM CT and held via Zoom, the SBBC meeting will deliver timely, actionable insights from leading experts in the field. Unlike traditional conferences that often demand considerable time and travel, this virtual platform allows busy oncologists from major cancer centers and regional clinics to participate without leaving their practice.

The agenda for the day is comprehensive, covering a spectrum of vital topics including acute leukemias like AML and ALL, chronic leukemias CML and CLL, myelodysplastic syndromes, myeloproliferative neoplasms, aggressive and indolent lymphomas, multiple myeloma, and cellular therapies. Each session is crafted to accommodate the hectic schedules of healthcare professionals while ensuring minimal disruption to patient care.

Participants will benefit from expert discussions led by a faculty of renowned hematologists such as Drs. Selina Luger, Eytan M. Stein, William Wierda, John O. Mascarenhas, among others. Each session will be designed with a 10-minute interactive question-and-answer period, allowing live engagement with Dr. Kantarjian. This format encourages discussions around challenging patient scenarios and aids in refining clinical decision-making processes.

Key discussion points will include innovative AML triplet regimens, strategies for measurable residual disease risk stratification, developments in noncovalent Bruton tyrosine kinase inhibitors for CLL, advances in fixed-duration treatment combinations, combating resistance mutations, and new quadruplet regimens emerging in the treatment of multiple myeloma, along with BCMA-targeted therapies.

This initiative is a reflection of SOHO's commitment to enhancing education and clinical practice in hematologic oncology. By providing a platform that is easily accessible and packed with valuable content, the SBBC meeting encourages practitioners around the world to stay updated with current advancements and improve their treatment approaches for blood cancers.

Registration for the event is now open, and it couldn't be easier to sign up. SOHO members can gain free access, while non-members may attend for a fee of $50. To facilitate smoother registration let’s not forget, healthcare professionals can register to attend the virtual sessions by visiting soho.click/SBBC.

Join the conversation, connect with other professionals, and enhance your practice at this sprawling event that epitomizes the future of medical education. Don’t miss out on the opportunity to stay at the forefront of breakthroughs in the battle against blood cancers.

Mark your calendars for November 20, 2025, and prepare to immerse yourself in a day filled with insight, innovation, and interaction. Together, we can advance the fight against blood cancers and improve patient outcomes across the globe.